Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-04-21 @ 3:17 PM
Study NCT ID:
NCT02066532
Status:
COMPLETED
Last Update Posted:
2023-08-24
First Post:
2014-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer
Sponsor:
Dawn L. Hershman
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AAAM1906
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None